| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polysaccharides | 13 | 2017 | 60 | 4.590 |
Why?
|
| Membrane Glycoproteins | 13 | 2021 | 143 | 3.150 |
Why?
|
| Mucins | 6 | 2017 | 22 | 2.350 |
Why?
|
| Lectins, C-Type | 6 | 2022 | 36 | 2.200 |
Why?
|
| Endothelial Cells | 14 | 2023 | 331 | 2.050 |
Why?
|
| Galactosyltransferases | 8 | 2017 | 16 | 2.030 |
Why?
|
| Blood Platelets | 7 | 2022 | 203 | 1.800 |
Why?
|
| Mucus | 4 | 2020 | 11 | 1.710 |
Why?
|
| Mice | 42 | 2024 | 4474 | 1.430 |
Why?
|
| Mice, Knockout | 22 | 2021 | 794 | 1.410 |
Why?
|
| Intestinal Mucosa | 5 | 2016 | 186 | 1.370 |
Why?
|
| Colon | 5 | 2020 | 119 | 1.330 |
Why?
|
| Lymphatic Vessels | 5 | 2021 | 20 | 1.330 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2022 | 216 | 1.280 |
Why?
|
| Megakaryocytes | 2 | 2021 | 29 | 1.230 |
Why?
|
| Animals | 47 | 2024 | 10085 | 1.220 |
Why?
|
| Colitis | 4 | 2016 | 53 | 1.160 |
Why?
|
| P-Selectin | 11 | 2011 | 30 | 1.110 |
Why?
|
| Platelet Activation | 5 | 2022 | 54 | 1.080 |
Why?
|
| von Willebrand Factor | 2 | 2022 | 36 | 0.990 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2024 | 4 | 0.930 |
Why?
|
| Glycosylation | 8 | 2020 | 69 | 0.900 |
Why?
|
| E-Selectin | 5 | 2010 | 27 | 0.890 |
Why?
|
| Mucin-2 | 2 | 2020 | 4 | 0.790 |
Why?
|
| Thrombosis | 2 | 2022 | 147 | 0.790 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 38 | 0.780 |
Why?
|
| N-Acetylglucosaminyltransferases | 4 | 2016 | 16 | 0.780 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 30 | 0.770 |
Why?
|
| Vascular Diseases | 1 | 2022 | 67 | 0.760 |
Why?
|
| Capillaries | 1 | 2021 | 32 | 0.750 |
Why?
|
| Cell Adhesion | 5 | 2024 | 133 | 0.740 |
Why?
|
| Disease Models, Animal | 11 | 2024 | 1405 | 0.740 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 4 | 2016 | 12 | 0.740 |
Why?
|
| Liver | 2 | 2021 | 424 | 0.730 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 122 | 0.730 |
Why?
|
| Neutrophils | 5 | 2017 | 179 | 0.730 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 64 | 0.730 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 111 | 0.720 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 55 | 0.710 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 133 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 13 | 2024 | 1496 | 0.700 |
Why?
|
| Brain | 2 | 2021 | 710 | 0.680 |
Why?
|
| Sialoglycoproteins | 2 | 2017 | 8 | 0.670 |
Why?
|
| Bone Diseases, Developmental | 1 | 2018 | 6 | 0.620 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 18 | 0.610 |
Why?
|
| Protein Transport | 2 | 2018 | 153 | 0.610 |
Why?
|
| Proprotein Convertases | 1 | 2018 | 11 | 0.610 |
Why?
|
| Lymphangiogenesis | 3 | 2016 | 6 | 0.610 |
Why?
|
| Signal Transduction | 7 | 2024 | 1379 | 0.600 |
Why?
|
| Endothelium, Vascular | 5 | 2017 | 305 | 0.590 |
Why?
|
| Podocytes | 1 | 2017 | 10 | 0.580 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 288 | 0.560 |
Why?
|
| Cells, Cultured | 13 | 2024 | 977 | 0.550 |
Why?
|
| Homeostasis | 2 | 2018 | 115 | 0.540 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 626 | 0.540 |
Why?
|
| Neovascularization, Pathologic | 4 | 2021 | 144 | 0.540 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 6 | 0.530 |
Why?
|
| Duodenum | 1 | 2016 | 15 | 0.530 |
Why?
|
| Thrombopoiesis | 1 | 2016 | 6 | 0.520 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 28 | 0.510 |
Why?
|
| Neovascularization, Physiologic | 4 | 2021 | 123 | 0.510 |
Why?
|
| Stromal Cells | 1 | 2016 | 60 | 0.510 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 58 | 0.510 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2008 | 15 | 0.500 |
Why?
|
| Atherosclerosis | 2 | 2024 | 95 | 0.490 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 114 | 0.490 |
Why?
|
| Humans | 26 | 2024 | 27121 | 0.480 |
Why?
|
| Cell Movement | 5 | 2014 | 353 | 0.470 |
Why?
|
| Cell Communication | 1 | 2014 | 66 | 0.450 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 4 | 2015 | 31 | 0.450 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2013 | 3 | 0.450 |
Why?
|
| Thalidomide | 1 | 2013 | 10 | 0.440 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 1 | 0.440 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 104 | 0.410 |
Why?
|
| ADAMTS13 Protein | 2 | 2022 | 126 | 0.390 |
Why?
|
| Aspirin | 2 | 2022 | 122 | 0.370 |
Why?
|
| Collagen | 3 | 2021 | 147 | 0.350 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 447 | 0.340 |
Why?
|
| Monocytes | 2 | 2024 | 132 | 0.330 |
Why?
|
| Platelet Aggregation | 2 | 2021 | 43 | 0.330 |
Why?
|
| Cell Proliferation | 5 | 2016 | 774 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 325 | 0.320 |
Why?
|
| Antigens, Ly | 1 | 2008 | 9 | 0.300 |
Why?
|
| Microvessels | 1 | 2008 | 86 | 0.290 |
Why?
|
| Fatty Liver | 1 | 2008 | 55 | 0.290 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 29 | 0.290 |
Why?
|
| Female | 10 | 2024 | 14636 | 0.270 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 72 | 0.270 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 440 | 0.270 |
Why?
|
| Intracranial Hemorrhages | 1 | 2006 | 30 | 0.250 |
Why?
|
| Colonic Neoplasms | 3 | 2017 | 116 | 0.250 |
Why?
|
| Leukocyte Rolling | 4 | 2011 | 7 | 0.250 |
Why?
|
| Bone Marrow Transplantation | 2 | 2005 | 42 | 0.240 |
Why?
|
| Male | 10 | 2024 | 13022 | 0.240 |
Why?
|
| Wnt Signaling Pathway | 2 | 2016 | 54 | 0.240 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 77 | 0.240 |
Why?
|
| Neutrophil Activation | 2 | 2017 | 6 | 0.240 |
Why?
|
| Fucose | 1 | 2004 | 5 | 0.230 |
Why?
|
| Talin | 1 | 2024 | 2 | 0.230 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2024 | 5 | 0.230 |
Why?
|
| Gestational Age | 2 | 2021 | 141 | 0.230 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 489 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2021 | 121 | 0.230 |
Why?
|
| Fetal Blood | 1 | 2004 | 38 | 0.230 |
Why?
|
| Myeloid Cells | 1 | 2024 | 26 | 0.230 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2004 | 2 | 0.230 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 455 | 0.230 |
Why?
|
| Mice, 129 Strain | 2 | 2016 | 9 | 0.230 |
Why?
|
| Mitral Valve Prolapse | 1 | 2023 | 21 | 0.220 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 26 | 0.210 |
Why?
|
| Mutation | 3 | 2018 | 818 | 0.210 |
Why?
|
| Leukocytes | 2 | 2015 | 68 | 0.210 |
Why?
|
| Receptor, TIE-2 | 2 | 2021 | 8 | 0.200 |
Why?
|
| Thiamine | 1 | 2022 | 6 | 0.200 |
Why?
|
| Hemolysis | 1 | 2022 | 46 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2022 | 15 | 0.200 |
Why?
|
| CHO Cells | 4 | 2014 | 96 | 0.200 |
Why?
|
| Analgesics | 1 | 2022 | 35 | 0.200 |
Why?
|
| Gene Deletion | 1 | 2022 | 116 | 0.200 |
Why?
|
| Hemorrhage | 1 | 2004 | 260 | 0.190 |
Why?
|
| Plasma Exchange | 1 | 2022 | 103 | 0.190 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.190 |
Why?
|
| Macrophages | 1 | 2024 | 279 | 0.190 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 20 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 401 | 0.190 |
Why?
|
| Ligands | 4 | 2015 | 169 | 0.190 |
Why?
|
| Diencephalon | 1 | 2021 | 3 | 0.190 |
Why?
|
| Angiopoietin-1 | 1 | 2021 | 8 | 0.190 |
Why?
|
| Aneurysm, Ruptured | 1 | 2021 | 17 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 131 | 0.180 |
Why?
|
| Flow Cytometry | 3 | 2014 | 285 | 0.180 |
Why?
|
| Golgi Apparatus | 2 | 2018 | 26 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 90 | 0.170 |
Why?
|
| Feces | 1 | 2020 | 107 | 0.170 |
Why?
|
| Mice, Inbred NOD | 2 | 2013 | 49 | 0.170 |
Why?
|
| L-Selectin | 2 | 2017 | 11 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 190 | 0.170 |
Why?
|
| Inflammation | 2 | 2022 | 608 | 0.160 |
Why?
|
| DNA Primers | 2 | 2011 | 143 | 0.160 |
Why?
|
| Lymphedema | 2 | 2015 | 14 | 0.160 |
Why?
|
| Mannosephosphates | 1 | 2018 | 5 | 0.150 |
Why?
|
| Proteolysis | 2 | 2016 | 55 | 0.150 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 31 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 20 | 0.150 |
Why?
|
| Chondrocytes | 1 | 2018 | 26 | 0.150 |
Why?
|
| Lipogenesis | 1 | 2018 | 29 | 0.150 |
Why?
|
| Sodium Salicylate | 1 | 1998 | 1 | 0.150 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1998 | 13 | 0.150 |
Why?
|
| Lysosomes | 1 | 2018 | 55 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2010 | 243 | 0.150 |
Why?
|
| Dexamethasone | 1 | 1998 | 54 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 115 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 67 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2014 | 40 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 60 | 0.140 |
Why?
|
| Cricetulus | 2 | 2014 | 56 | 0.140 |
Why?
|
| Membrane Microdomains | 2 | 2015 | 36 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 7 | 0.140 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2013 | 7 | 0.140 |
Why?
|
| Phenotype | 2 | 2016 | 667 | 0.140 |
Why?
|
| Intercellular Junctions | 2 | 2013 | 8 | 0.140 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 162 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 55 | 0.130 |
Why?
|
| Duodenitis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2014 | 97 | 0.130 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 4 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 24 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 251 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 278 | 0.130 |
Why?
|
| beta Catenin | 1 | 2016 | 62 | 0.130 |
Why?
|
| Antioxidants | 1 | 1998 | 220 | 0.130 |
Why?
|
| Venous Valves | 1 | 2015 | 1 | 0.130 |
Why?
|
| Genes, erbB-2 | 1 | 2015 | 3 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 138 | 0.120 |
Why?
|
| Cell Survival | 1 | 2017 | 395 | 0.120 |
Why?
|
| Cell Line | 2 | 2016 | 682 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 177 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2023 | 512 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 445 | 0.120 |
Why?
|
| Sialic Acids | 1 | 2014 | 1 | 0.120 |
Why?
|
| Platelet Adhesiveness | 1 | 2014 | 6 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Lymphatic System | 1 | 2014 | 11 | 0.120 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2014 | 14 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2018 | 1100 | 0.120 |
Why?
|
| Apoptosis | 1 | 2018 | 740 | 0.120 |
Why?
|
| Dipeptides | 1 | 2014 | 22 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2015 | 116 | 0.120 |
Why?
|
| Hyaluronan Receptors | 2 | 2015 | 30 | 0.120 |
Why?
|
| Binding Sites | 4 | 2015 | 342 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 54 | 0.120 |
Why?
|
| Fucosyltransferases | 2 | 2004 | 4 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 161 | 0.110 |
Why?
|
| Sphingosine | 1 | 2013 | 22 | 0.110 |
Why?
|
| Cadherins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Random Allocation | 1 | 2013 | 148 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 48 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2013 | 48 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 655 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2013 | 134 | 0.100 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 50 | 0.100 |
Why?
|
| Base Sequence | 3 | 2011 | 575 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 24 | 0.100 |
Why?
|
| Intestines | 1 | 2013 | 117 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 42 | 0.100 |
Why?
|
| Aorta | 3 | 2024 | 123 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 497 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2011 | 10 | 0.100 |
Why?
|
| Nicotine | 1 | 2012 | 82 | 0.090 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 10 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 49 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2011 | 53 | 0.090 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 4 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 123 | 0.090 |
Why?
|
| Cricetinae | 3 | 2011 | 129 | 0.080 |
Why?
|
| CD18 Antigens | 2 | 2024 | 14 | 0.080 |
Why?
|
| Transgenes | 1 | 2008 | 59 | 0.080 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2008 | 12 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 12 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2008 | 44 | 0.080 |
Why?
|
| Time Factors | 4 | 2014 | 1570 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2008 | 648 | 0.070 |
Why?
|
| Protein Binding | 2 | 2015 | 637 | 0.070 |
Why?
|
| NF-kappa B | 2 | 1998 | 187 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 80 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2007 | 123 | 0.070 |
Why?
|
| Peptides | 2 | 1999 | 283 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 318 | 0.070 |
Why?
|
| Transfection | 3 | 2002 | 314 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2006 | 17 | 0.060 |
Why?
|
| Lipopolysaccharides | 3 | 2010 | 156 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2005 | 5 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 679 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2005 | 76 | 0.060 |
Why?
|
| Lewis X Antigen | 1 | 2004 | 2 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2004 | 13 | 0.060 |
Why?
|
| Integrin alpha4beta1 | 1 | 2024 | 4 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 13 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2004 | 59 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2024 | 16 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 80 | 0.060 |
Why?
|
| Pericytes | 1 | 2004 | 17 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 79 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 48 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 132 | 0.050 |
Why?
|
| Leukosialin | 2 | 2015 | 2 | 0.050 |
Why?
|
| Endocytosis | 2 | 2014 | 81 | 0.050 |
Why?
|
| Epitopes | 1 | 2004 | 181 | 0.050 |
Why?
|
| Microcirculation | 1 | 2004 | 112 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2023 | 58 | 0.050 |
Why?
|
| Gene Expression | 2 | 2010 | 408 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 111 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2004 | 116 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 21 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 102 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 129 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 92 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 28 | 0.050 |
Why?
|
| Cattle | 3 | 1998 | 383 | 0.050 |
Why?
|
| Sulfates | 1 | 2002 | 86 | 0.050 |
Why?
|
| Oncostatin M | 2 | 1999 | 4 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1998 | 25 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2015 | 178 | 0.050 |
Why?
|
| Pregnancy | 1 | 2004 | 1149 | 0.040 |
Why?
|
| Models, Biological | 2 | 2014 | 448 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 283 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2015 | 398 | 0.040 |
Why?
|
| Carbon Tetrachloride | 1 | 2018 | 8 | 0.040 |
Why?
|
| Leupeptins | 1 | 1998 | 7 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| Thiocarbamates | 1 | 1998 | 6 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 1998 | 11 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 25 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 1998 | 23 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 1998 | 25 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 18 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2017 | 39 | 0.030 |
Why?
|
| Genes, APC | 1 | 2017 | 14 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 26 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1998 | 229 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 82 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 119 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 331 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 34 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 98 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 110 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 64 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1041 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 5 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cytokines | 1 | 1998 | 440 | 0.030 |
Why?
|
| Dishevelled Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 19 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2015 | 17 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 27 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2015 | 18 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 24 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 42 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 55 | 0.030 |
Why?
|
| Lymph | 1 | 2014 | 5 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2017 | 330 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2014 | 21 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 122 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 195 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 98 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 345 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2017 | 467 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 198 | 0.030 |
Why?
|
| Zebrafish | 1 | 2014 | 95 | 0.030 |
Why?
|
| Wound Healing | 1 | 2013 | 113 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 88 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2012 | 38 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2012 | 108 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2012 | 54 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 175 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2005 | 87 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 77 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2011 | 9 | 0.020 |
Why?
|
| Cathepsin G | 1 | 2011 | 6 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 2011 | 7 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 78 | 0.020 |
Why?
|
| Thioglycolates | 1 | 2010 | 2 | 0.020 |
Why?
|
| Venules | 1 | 2010 | 3 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 69 | 0.020 |
Why?
|
| Peritonitis | 1 | 2010 | 15 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 568 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 61 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 280 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2011 | 236 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 506 | 0.020 |
Why?
|
| Species Specificity | 2 | 1999 | 187 | 0.020 |
Why?
|
| Microvilli | 1 | 2008 | 7 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2008 | 12 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1998 | 47 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 58 | 0.020 |
Why?
|
| Luciferases | 2 | 1998 | 49 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 1998 | 111 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 465 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 240 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 96 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1268 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 229 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 408 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 200 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2008 | 445 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2005 | 23 | 0.020 |
Why?
|
| Cell Count | 1 | 2005 | 85 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 411 | 0.010 |
Why?
|
| Primates | 1 | 1999 | 22 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 20 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 17 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 54 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 65 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 22 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 245 | 0.010 |
Why?
|